Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 656 results for "biocon"

Price control debate: Is the pharma sector crying 'wolf'?
Money Control

NPPA's unilateral stand-off unhealthy for sector: Biocon

CII National Committee on Biotechnology Chairperson and Biocon CMD Kiran Mazumdar Shaw has written an open letter to the Prime Minister, seeking his intervention over "unilateral fixing" of drug prices by NPPA . Money Control, 4 hours ago

206 images for biocon

4 Traders, 10 hours ago
Oneindia, 2 days ago
Financial Express, 3 days ago
India TV, 3 days ago
Financial Express, 3 days ago, 3 days ago
MSN India, 3 days ago
Sify, 3 days ago
NDTV, 4 hours ago
Money Control, 3 days ago
Business Standard India

Biocon's R&D spend up by 15%

Biocon Ltd, the Bangalore-based biotech major, has increased gross R&D expenditure by nearly 15%. The company, which has R&D as a key focus, saw its gross R&D spends at Rs 54 crore, which is about 10 per cent of the company's biopharmaceutical ...
 Business Standard India11 hours ago Corporate : Biocon raises R&D expenditure by 15%  Indian-Commodity2 days ago Biocon ups R&D expenses by 15%  Smart Investor2 days ago Biocon planning to list Syngene in near-term: CMD  Money Control1 month ago
NDTV Profit

Industry Body Seeks Prime Minister's Intervention Over Drug Price Fixing

File photo of Biocon chief Kiran Mazumdar-Shaw New Delhi : Industry chamber CII has sought Prime Minister Narendra Modi's intervention over "unilateral fixing" of drug prices by the National Pharmaceutical Pricing Authority (NPPA) saying the ...
 NDTV Profit6 hours ago
DNA India

Biocon chief seeks PM's intervention to solve issues being faced by pharma industry

The National Pharmaceutical Pricing Authority's (NPPA) decision to impose ceiling prices on 348 essential drugs under the National List of Essential Medicines (NLEM), by adopting a simple average price formula, has been to the industry's ...
 PharmaBiz10 hours ago NPPA moves to bring cancer drugs under price control regime  4 Traders6 days ago National Pharmaceutical Pricing Authority moves to bring cancer drugs under price control  DNA India1 week ago

BIOCON : files first new drug applications

Mumbai : Bangalore -based Biocon on Friday said it has filed its first abbreviated new drug applications (ANDAs) targeting the US generics market during the June quarter. Kiran Mazumdar-Shaw , chairman and managing director, said, "We have filed ...
 4 Traders9 hours ago Biocon files its first new drug applications  DNA2 days ago Biocon files first new drug applications [DNA : Daily News & Analysis (India)]  Pharmacy Choice8 hours ago
New Indian Express

Biocon net up 9% on higher licensing revenues

Bangalore based biopharmaceutical company Biocon on Friday reported 9 per cent increase in net profit to Rs 103 crore for the quarter ended June 30 from Rs 94 crore in the corresponding quarter last year on the back of increased licensing revenue. The quarter ...
 Deccan Herald2 days ago Biocon Posts 9% Growth in Net at Rs 103 cr  New Indian Express3 days ago Biocon profit up 9% in Q1  Hindu Business Line3 days ago Biocon shares sink more than 7%  Financial Express3 days ago

Biocon shares sink more than 7%

Shares of biotechnology major Biocon fell sharply by over 7 per cent today as it posted muted earnings for April-June quarter. Biocon's scrip ended the day at Rs 480.30, down 7.07 per cent from its previous close on the BSE. In intra-day trade, ...
 Business Standard3 days ago Biocon Shares Fall as Earnings Disappoint  NDTV Profit3 days ago Biocon shares fall as June-quarter earnings disappoint  Economic Times3 days ago Biocon down over 7% on poor Q1 show  Economic Times3 days ago

RD spends expected to increase significantly: Biocon

According to the management, the flagship biopharma business of the company, which contributes close to 75 percent of the revenues, was impacted this quarter due to geopolitical tensions in Middle East.
 Money Control3 days ago Biocon declines 5% as Q1 growth lags estimates  Smart Investor3 days ago

Biocon posts Q1 FY15 results

Revenues recorded at Rs 742 crores, EBITDA at Rs 191 crores and PAT at Rs 103 crores Biocon has posted Q1 FY15 results. The company has recorded revenues at Rs 742 crores. EBITDA at Rs 191 crores and PAT at Rs 103 crores. The biopharma segment ...
 Express Pharma3 days ago Biocon stock dips 6%  India Infoline3 days ago Biocon slips after Q1 results  India Infoline3 days ago Biocon : announces Q1 FY15 results...  4 Traders3 days ago

Here are top 10 stocks to focus on July 25

Here are top 10 stocks to focus on July 25 - Cairn, HDFC, Ambuja Cement, Wipro, SKS Micro, MM Financial, TVS Motor, Biocon, Glenmark and Adani Power
 Money Control3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less